Cargando…

Constitutively active microglial populations limit anorexia induced by the food contaminant deoxynivalenol

Microglia are involved in neuroinflammatory processes during diverse pathophysiological conditions. To date, the possible contribution of these cells to deoxynivalenol (DON)-induced brain inflammation and anorexia has not yet been evaluated. DON, one of the most abundant trichothecenes found in cere...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaige, Stéphanie, Barbouche, Rym, Barbot, Manon, Boularand, Sarah, Dallaporta, Michel, Abysique, Anne, Troadec, Jean-Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675145/
https://www.ncbi.nlm.nih.gov/pubmed/36403004
http://dx.doi.org/10.1186/s12974-022-02631-7
_version_ 1784833306158694400
author Gaige, Stéphanie
Barbouche, Rym
Barbot, Manon
Boularand, Sarah
Dallaporta, Michel
Abysique, Anne
Troadec, Jean-Denis
author_facet Gaige, Stéphanie
Barbouche, Rym
Barbot, Manon
Boularand, Sarah
Dallaporta, Michel
Abysique, Anne
Troadec, Jean-Denis
author_sort Gaige, Stéphanie
collection PubMed
description Microglia are involved in neuroinflammatory processes during diverse pathophysiological conditions. To date, the possible contribution of these cells to deoxynivalenol (DON)-induced brain inflammation and anorexia has not yet been evaluated. DON, one of the most abundant trichothecenes found in cereals, has been implicated in mycotoxicosis in both humans and farm animals. DON-induced toxicity is characterized by reduced food intake, weight gain, and immunological effects. We previously showed that exposure to DON induces an inflammatory response within the hypothalamus and dorsal vagal complex (DVC) which contributes to DON-induced anorexia. Here, in response to anorectic DON doses, we reported microglial activation within two circumventricular organs (CVOs), the area postrema (AP) and median eminence (ME) located in the DVC and the hypothalamus, respectively. Interestingly, this microglial activation was observed while DON-induced anorexia was ongoing (i.e., 3 and 6 h after DON administration). Next, we took advantage of pharmacological microglia deletion using PLX3397, a colony-stimulating factor 1 receptor (CSF1R)-inhibitor. Surprisingly, microglia-depleted mice exhibited an increased sensitivity to DON since non-anorectic DON doses reduced food intake in PLX3397-treated mice. Moreover, low DON doses induced c-Fos expression within feeding behavior-associated structures in PLX3397-treated mice but not in control mice. In parallel, we have highlighted heterogeneity in the phenotype of microglial cells present in and around the AP and ME of control animals. In these areas, microglial subpopulations expressed IBA1, TMEM119, CD11b and CD68 to varying degrees. In addition, a CD68 positive subpopulation showed, under resting conditions, a noticeable phagocytotic/endocytotic activity. We observed that DON strongly reduced CD68 in the hypothalamus and DVC. Finally, inactivation of constitutively active microglia by intraperitoneal administration of minocycline resulted in anorexia with a DON dose ineffective in control mice. Taken together, these results strongly suggest that various populations of microglial cells residing in and around the CVOs are maintained in a functionally active state even under physiological conditions. We propose that these microglial cell populations are attempting to protect the brain parenchyma from hazardous molecules coming from the blood. This study could contribute to a better understanding of how microglia respond to environmental contaminants. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-022-02631-7.
format Online
Article
Text
id pubmed-9675145
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96751452022-11-20 Constitutively active microglial populations limit anorexia induced by the food contaminant deoxynivalenol Gaige, Stéphanie Barbouche, Rym Barbot, Manon Boularand, Sarah Dallaporta, Michel Abysique, Anne Troadec, Jean-Denis J Neuroinflammation Research Microglia are involved in neuroinflammatory processes during diverse pathophysiological conditions. To date, the possible contribution of these cells to deoxynivalenol (DON)-induced brain inflammation and anorexia has not yet been evaluated. DON, one of the most abundant trichothecenes found in cereals, has been implicated in mycotoxicosis in both humans and farm animals. DON-induced toxicity is characterized by reduced food intake, weight gain, and immunological effects. We previously showed that exposure to DON induces an inflammatory response within the hypothalamus and dorsal vagal complex (DVC) which contributes to DON-induced anorexia. Here, in response to anorectic DON doses, we reported microglial activation within two circumventricular organs (CVOs), the area postrema (AP) and median eminence (ME) located in the DVC and the hypothalamus, respectively. Interestingly, this microglial activation was observed while DON-induced anorexia was ongoing (i.e., 3 and 6 h after DON administration). Next, we took advantage of pharmacological microglia deletion using PLX3397, a colony-stimulating factor 1 receptor (CSF1R)-inhibitor. Surprisingly, microglia-depleted mice exhibited an increased sensitivity to DON since non-anorectic DON doses reduced food intake in PLX3397-treated mice. Moreover, low DON doses induced c-Fos expression within feeding behavior-associated structures in PLX3397-treated mice but not in control mice. In parallel, we have highlighted heterogeneity in the phenotype of microglial cells present in and around the AP and ME of control animals. In these areas, microglial subpopulations expressed IBA1, TMEM119, CD11b and CD68 to varying degrees. In addition, a CD68 positive subpopulation showed, under resting conditions, a noticeable phagocytotic/endocytotic activity. We observed that DON strongly reduced CD68 in the hypothalamus and DVC. Finally, inactivation of constitutively active microglia by intraperitoneal administration of minocycline resulted in anorexia with a DON dose ineffective in control mice. Taken together, these results strongly suggest that various populations of microglial cells residing in and around the CVOs are maintained in a functionally active state even under physiological conditions. We propose that these microglial cell populations are attempting to protect the brain parenchyma from hazardous molecules coming from the blood. This study could contribute to a better understanding of how microglia respond to environmental contaminants. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-022-02631-7. BioMed Central 2022-11-19 /pmc/articles/PMC9675145/ /pubmed/36403004 http://dx.doi.org/10.1186/s12974-022-02631-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Gaige, Stéphanie
Barbouche, Rym
Barbot, Manon
Boularand, Sarah
Dallaporta, Michel
Abysique, Anne
Troadec, Jean-Denis
Constitutively active microglial populations limit anorexia induced by the food contaminant deoxynivalenol
title Constitutively active microglial populations limit anorexia induced by the food contaminant deoxynivalenol
title_full Constitutively active microglial populations limit anorexia induced by the food contaminant deoxynivalenol
title_fullStr Constitutively active microglial populations limit anorexia induced by the food contaminant deoxynivalenol
title_full_unstemmed Constitutively active microglial populations limit anorexia induced by the food contaminant deoxynivalenol
title_short Constitutively active microglial populations limit anorexia induced by the food contaminant deoxynivalenol
title_sort constitutively active microglial populations limit anorexia induced by the food contaminant deoxynivalenol
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675145/
https://www.ncbi.nlm.nih.gov/pubmed/36403004
http://dx.doi.org/10.1186/s12974-022-02631-7
work_keys_str_mv AT gaigestephanie constitutivelyactivemicroglialpopulationslimitanorexiainducedbythefoodcontaminantdeoxynivalenol
AT barboucherym constitutivelyactivemicroglialpopulationslimitanorexiainducedbythefoodcontaminantdeoxynivalenol
AT barbotmanon constitutivelyactivemicroglialpopulationslimitanorexiainducedbythefoodcontaminantdeoxynivalenol
AT boularandsarah constitutivelyactivemicroglialpopulationslimitanorexiainducedbythefoodcontaminantdeoxynivalenol
AT dallaportamichel constitutivelyactivemicroglialpopulationslimitanorexiainducedbythefoodcontaminantdeoxynivalenol
AT abysiqueanne constitutivelyactivemicroglialpopulationslimitanorexiainducedbythefoodcontaminantdeoxynivalenol
AT troadecjeandenis constitutivelyactivemicroglialpopulationslimitanorexiainducedbythefoodcontaminantdeoxynivalenol